Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 27, Issue 2, Pages 63-73
http://dx.doi.org/10.3233/DMA-2009-0651

Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis

Anat Achiron, Anna Feldman, and Michael Gurevich

Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, and Sackler School of Medicine, Tel-Aviv University, Israel

Received 28 October 2009; Accepted 28 October 2009

Copyright © 2009 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Anat Achiron, Anna Feldman, and Michael Gurevich, “Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis,” Disease Markers, vol. 27, no. 2, pp. 63-73, 2009. https://doi.org/10.3233/DMA-2009-0651.